Asset Management Corp Checkpoint Therapeutics, Inc. Transaction History

Asset Management Corp

  • $146 Million
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022
SELL
$2.68 - $4.46 $229,810 - $382,445
-85,750 Closed
0 $0
Q3 2021

Oct 13, 2021
SELL
$2.5 - $3.53 $12,500 - $17,650
-5,000 Reduced 5.51%
85,750 $283,000
Q2 2021

Aug 06, 2021
BUY
$2.36 - $3.2 $214,170 - $290,400
90,750 New
90,750 $268,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $321M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Asset Management Corp Portfolio

Follow Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email